Subscribe

Pharma

Navigating the Pharmaceutical Marketing Landscape: Research Trends for Fall

Navigating the Pharmaceutical Marketing Landscape: Research Trends for Fall

The pharmaceutical industry is continually evolving, with marketing strategies playing a pivotal role in the success of pharmaceutical products. As we transition into the fall season, it's an opportune time to explore the latest trends and advancements in pharmaceutical marketing research. In this blog post, we'll

Drug Approvals in 2023

Drug Approvals in 2023

The year 2023 has seen a number of important drug approvals, both for new drugs and for new indications for existing drugs. Here are some of the most notable approvals: * Dostarlimab: Dostarlimab is a first-in-class drug that has been approved for the treatment of advanced rectal cancer. Dostarlimab is a

Top 5 Most Profitable Pharmaceutical Companies in the World

Top 5 Most Profitable Pharmaceutical Companies in the World

The pharmaceutical industry is a global business that is worth trillions of dollars. The top pharmaceutical companies in the world are responsible for developing and manufacturing life-saving drugs, and they generate billions of dollars in revenue each year. Here is a list of the top 5 most profitable pharmaceutical companies

Artificial Intelligence in the Pharmaceutical Industry

Artificial Intelligence in the Pharmaceutical Industry

Artificial intelligence (AI) is rapidly transforming the pharmaceutical industry. AI is being used to improve drug discovery, development, and manufacturing. Drug discovery AI is being used to identify new drug targets, design new drug molecules, and predict the efficacy and toxicity of new drugs. * Target identification: AI can be used

Pfizer expansion upwards of €1.2B in Ireland

Pfizer expansion upwards of €1.2B in Ireland

After committing to a significant expansion in Ireland, Pfizer is now moving east into continental Europe. Just one day after plotting an identical investment in Dublin, the company announced it would invest 1.2 billion euros in Puurs, Belgium. Pfizer said in a press release that some projects in Belgium

COVID-19 tracker: Novavax pulls out of Gavi supply arrangement, citing "material breach"

COVID-19 tracker: Novavax pulls out of Gavi supply arrangement, citing "material breach"

A vaccine supply agreement for low- and middle-income nations was terminated by Novavax. In Japan, Shionogi received regulatory approval for its antiviral. Additionally, authorities in China are raising the alarm about an increase in instances. For the most recent updates, please read below. You may read the daily COVID-19 tracker